Publication | Open Access
A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia
34
Citations
23
References
2021
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1